Pulmonary disease includes a group of conditions that are either obstructive or restrictive in nature. Understanding disease pathophysiology in the pulmonary patient lends to optimizing interventions and promoting best outcomes. Any abnormal condition of the respiratory system, characterized by cough, chest pain, dyspnea, hemoptysis, sputum production, stridor, or adventitious lung sounds require early evaluation and management.
Nearly 34 million Americans live with pulmonary disease such as asthma (restrictive) and chronic obstructive pulmonary disease (obstructive). Preventing worsening of pulmonary function is a key element in meeting the healthcare needs of this patient population.
Use of shared decision making, patient engagement, and self-management practices can help to reduce the incidence of disease exacerbation and prevent progression and worsening in lung function and maintain physical function.